Additionally, subject HU2073 having T1D for 50 years increased the percentage of GLUT2+CD45RO+ PB-IPC from 2.14% at baseline to 71.1% at the first month follow-up, which may potentially contribute to the marked improvement in the neuropathy of his foot after receiving stem cell educator therapy. The gene discussed is SLC2A2; the disease is type 1 diabetes mellitus.